These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25880400)

  • 1. Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine.
    Fu CH; Costafreda SG; Sankar A; Adams TM; Rasenick MM; Liu P; Donati R; Maglanoc LA; Horton P; Marangell LB
    BMC Psychiatry; 2015 Apr; 15():82. PubMed ID: 25880400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.
    Victor TA; Furey ML; Fromm SJ; Öhman A; Drevets WC
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2195-208. PubMed ID: 23809145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder.
    Victor TA; Furey ML; Fromm SJ; Ohman A; Drevets WC
    Arch Gen Psychiatry; 2010 Nov; 67(11):1128-38. PubMed ID: 21041614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eight-week antidepressant treatment reduces functional connectivity in first-episode drug-naïve patients with major depressive disorder.
    Li L; Su YA; Wu YK; Castellanos FX; Li K; Li JT; Si TM; Yan CG
    Hum Brain Mapp; 2021 Jun; 42(8):2593-2605. PubMed ID: 33638263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study.
    Ruhé HG; Booij J; Veltman DJ; Michel MC; Schene AH
    J Clin Psychiatry; 2012 Apr; 73(4):451-9. PubMed ID: 21903032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal functional connectivity strength in first-episode, drug-naïve adult patients with major depressive disorder.
    Shi Y; Li J; Feng Z; Xie H; Duan J; Chen F; Yang H
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109759. PubMed ID: 31499128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants normalize the default mode network in patients with dysthymia.
    Posner J; Hellerstein DJ; Gat I; Mechling A; Klahr K; Wang Z; McGrath PJ; Stewart JW; Peterson BS
    JAMA Psychiatry; 2013 Apr; 70(4):373-82. PubMed ID: 23389382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attributes of response in depressed patients switched to treatment with duloxetine.
    Sagman D; McIntosh D; Lee MS; Li H; Ruschel S; Hussain N; Granger RE; Lee AC; Raskin J
    Int J Clin Pract; 2011 Jan; 65(1):73-81. PubMed ID: 21078010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery.
    Herrera-Guzmán I; Gudayol-Ferré E; Herrera-Abarca JE; Herrera-Guzmán D; Montelongo-Pedraza P; Padrós Blázquez F; Peró-Cebollero M; Guàrdia-Olmos J
    J Affect Disord; 2010 Jun; 123(1-3):341-50. PubMed ID: 19896719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the effect of escitalopram treatment on amplitude of low-frequency fluctuations in patients with depression: a resting-state fMRI study.
    Wang L; Li X; Li K; Su Y; Zeng Y; Zhang Q; Wang G; Jin Z; Kong Q; Si T
    Metab Brain Dis; 2017 Feb; 32(1):147-154. PubMed ID: 27524655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antidepressant treatment on resting-state functional brain networks in patients with major depressive disorder.
    Wang L; Xia M; Li K; Zeng Y; Su Y; Dai W; Zhang Q; Jin Z; Mitchell PB; Yu X; He Y; Si T
    Hum Brain Mapp; 2015 Feb; 36(2):768-78. PubMed ID: 25332057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of a dissociation pattern in resting-state default mode network connectivity in first-episode, treatment-naive major depression patients.
    Zhu X; Wang X; Xiao J; Liao J; Zhong M; Wang W; Yao S
    Biol Psychiatry; 2012 Apr; 71(7):611-7. PubMed ID: 22177602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with escitalopram improves the attentional bias toward negative facial expressions in patients with major depressive disorders.
    Zhou Z; Cao S; Li H; Li Y
    J Clin Neurosci; 2015 Oct; 22(10):1609-13. PubMed ID: 26149404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.
    Martinez JM; Katon W; Greist JH; Kroenke K; Thase ME; Meyers AL; Edwards SE; Marangell LB; Shoemaker S; Swindle R
    Int Clin Psychopharmacol; 2012 Jan; 27(1):17-26. PubMed ID: 22027844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study.
    Miller JM; Schneck N; Siegle GJ; Chen Y; Ogden RT; Kikuchi T; Oquendo MA; Mann JJ; Parsey RV
    Psychiatry Res; 2013 Dec; 214(3):296-305. PubMed ID: 24446548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NGF serum levels variations in major depressed patients receiving duloxetine.
    Martino M; Rocchi G; Escelsior A; Contini P; Colicchio S; de Berardis D; Amore M; Fornaro P; Fornaro M
    Psychoneuroendocrinology; 2013 Sep; 38(9):1824-8. PubMed ID: 23507186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of selective serotonin reuptake inhibitor on prefrontal-striatal connectivity is dependent on the level of TNF-α in patients with major depressive disorder.
    Liu K; Zhao X; Lu X; Zhu X; Chen H; Wang M; Yan W; Jing L; Deng Y; Yu L; Wu H; Wen G; Sun X; Lv Z
    Psychol Med; 2019 Nov; 49(15):2608-2616. PubMed ID: 30520409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-week administration of the combined serotonin-noradrenaline reuptake inhibitor duloxetine augments functioning of mesolimbic incentive processing circuits.
    Ossewaarde L; Verkes RJ; Hermans EJ; Kooijman SC; Urner M; Tendolkar I; van Wingen GA; Fernández G
    Biol Psychiatry; 2011 Sep; 70(6):568-74. PubMed ID: 21601833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
    Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
    Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.